Physician

Amjad Iqbal, M.D.

According to 2025 Medicare claims, Amjad Iqbal, M.D. (NPI: 1942209168) practices cardiology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is ADVANCED CARDIOVASCULAR CENTER, INC (NPI: 1568668200; TIN: 208952950) and primary practice location at 44718-2532. Iqbal is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729) and IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Iqbal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 714 traditional Medicare patients, billed 5,216 HCPCS/CPT codes, and received $307,447 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 18,333 prescription claims across 1,606 beneficiaries totaling $2,002,522 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 11 claims. Open Payments data shows 74 records totaling $1,212. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $630,238 to $2,002,522. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,932 to $110.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,168	6,430	$410,435
2016	1,052	6,162	$381,165
2017	1,012	6,462	$402,035
2018	1,554	7,812	$501,975
2019	1,455	7,876	$516,361
2020	1,198	6,624	$413,035
2021	1,144	6,499	$423,173
2022	984	6,299	$411,974
2023	776	5,788	$375,608
2024	714	5,216	$307,447

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	950	12,063	$630,238
2016	1,061	13,391	$738,670
2017	1,121	14,882	$914,554
2018	1,275	16,006	$1,066,880
2019	1,398	16,459	$1,253,834
2020	1,487	16,393	$1,408,701
2021	1,541	17,510	$1,483,305
2022	1,578	18,317	$1,664,374
2023	1,595	18,929	$2,051,910
2024	1,606	18,333	$2,002,522

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$1,844
2016	N/R	N/R	N/R
2017	N/R	11	$371
2018	N/R	N/R	N/R
2019	N/R	11	$110
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	178	178	$304
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	297	297	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	673	1,649	$82
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	181	181	$44
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	689	1,508	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	986	47,847	$914,499
Xarelto	Rivaroxaban	457	24,562	$448,816
Entresto	Sacubitril/Valsartan	182	7,536	$157,752
Repatha Sureclick	Evolocumab	100	7,880	$146,782
Vascepa	Icosapent Ethyl	24	1,863	$20,289

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$1,212	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amjad Iqbal, M.D.?

Tedicare shows public-source Medicare data for Amjad Iqbal, M.D. (NPI 1942209168), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amjad Iqbal, M.D. have ACO affiliation data?

Amjad Iqbal, M.D. is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729) and IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Amjad Iqbal, M.D.?

Amjad Iqbal, M.D. is linked to ADVANCED CARDIOVASCULAR CENTER, INC (billing NPI 1568668200) in the available physician profile data.

Does Amjad Iqbal, M.D. have Open Payments data?

Amjad Iqbal, M.D. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.